DailyMail
-
Barclays wields axe in £10bn bid to woo investors as boss hails Britain's 'resilient' economy
Barclays, led by boss Venkat (pictured), is targeting £2bn in savings and a £10bn in dividends and buy-backs
-
Currys backer warns of UK market decline after board rejects £700m takeover offer by US hedge fund
Redwheel, which owns 14.6% of Currys, backed the decision by the electrical retailer's board to reject a £700m takeover offer by Elliott Partners.
-
Nearly half of The Body Shop stores to shut as High Street chain battles for survival
The company had 198 shops in Britain and 2,200 staff when it tumbled into administration last week in a major blow to the High Street.
-
New report confirms UK debanking fears: Customers being dumped because of opinions or lifestyles
Last year, Coutts, the private bank owned by NatWest, ditched former Ukip and Brexit Party leader Nigel Farage (pictured) over his views.
-
Nightcap shares slump as takeover is overshadowed by bar group's weak start to the year
The bar operator, co-founded by former Dragons Den star Sarah Willingham, saw its share price slump after saying trading had been 'far softer' than...
-
Competition watchdog to probe baby formula market as costs soar
A CMA report released last November on the grocery sector found Britons could save more than £500 in the first year of a baby's life by switching...
-
BUSINESS LIVE: Barclays overhaul; IHG's profits top $1bn; CMA baby formula probe
Among the companies with reports and trading updates today are Barclays, IHG, Plus500 and Nightcap.
-
Plus500 reveals £140m in shareholder payouts as profits smash forecasts
Plus500 has revealed shareholder payouts worth $175million (£139million) in buybacks and dividends after annual profits beat expectations.
-
Barclays targets £2bn in cost savings as lender vows £10bn in payouts over the next three years
In its first significant strategy update since 2016, Britain's second-biggest bank wants to cut its cost-to-income ratio from 63 per cent in 2023...
-
MARKET REPORT: Lung cancer drug gives AstraZeneca a shot in arm
The pharma giant's drug Tagrisso, a tablet taken once a day, alongside chemotherapy delayed the disease progressing by nearly nine months.
-
Eurostar faces backlash as passengers hit by half-term strikes struggle to get refunds
Travellers saw their journeys disrupted over the weekend after a walk-out by French train staff caused cross-Channel services to be cancelled.
-
Aldi fires up price war with fresh round of reductions on fruit and vegetables
Aldi overtook Morrisons to become Britain's fourth-biggest grocer two years ago. It is now cutting the prices of over 50 items by an average of 7%.